Fill and Finish Manufacturing Network (FFMN)

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded this Master IDIQ on September 30, 2013, to establish domestic pharmaceutical fill and finish manufacturing capacity for medical countermeasures and public health emergency products, with ordering closed since September 29, 2023.

This vehicle is no longer active for new task-order competition. The last order was placed in August 2021, more than four years ago, and the ordering period ended nearly three years ago. The vehicle established a network of U.S.-based fill and finish facilities to support influenza vaccine and other MCM surge capacity on a cost-effective, reliable, and sustainable basis.

The prime contractor field is concentrated among four firms. Catalent Indiana LLC holds the largest share by potential value, with three orders totaling $29.6 million combined potential value. Resilience Government Services, Inc. leads by order count with four awards totaling $24.8 million combined potential value. Par Sterile Products, LLC accounts for two orders valued at $9.4 million, and Patheon Manufacturing Services LLC holds one order with zero combined potential value. The portfolio shows front-loaded activity in the initial award year (2013), with most orders placed in the first five years; activity tapered significantly after 2019, with only one order in 2021 before the ordering window closed.

All ten task orders were placed by the same customer—ASPR within HHS—eliminating customer concentration variation. All orders carried no set-aside designation. The combined task-order potential value across the network totaled $63.8 million, though obligated dollars reached $64.5 million (101% of potential value), indicating at least one order was obligated above its ceiling value. Task-order ceilings ranged from zero to $13.9 million, with most structured as cost-plus-fixed-fee arrangements except for two later Catalent orders priced as firm-fixed-price. Most task orders completed between 2017 and 2022, aligned with government preparedness and pandemic-response timelines.

The United States Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) has awarded a Master IDIQ for Fill and Finish Manufacturing Network (FFMN) that facilitates medical countermeasure (MCM) and ensures domestic pharmaceutical surge fill and finish capacity. These fill and finish U.S. based Facilities are expected to provide filling and finishing capabilities for influenza vaccines and other public health emergency products to address national security and to augment public health needs on a cost- effective, reliable, and sustainable basis.